LacriJet® is FCI latest and exclusive preloaded and self-retaining monocanalicular nasolacrimal intubation indicated for epiphora, congenital nasolacrimal duct obstruction and canalicular laceration.
Popular Links
Questions about our products?
FCI Ophthalmics
[email protected]
Phone : 800-932-4202
Fax : 781-826-9060